FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 60 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $179,782,000 | +189.6% | 9,011,651 | 0.0% | 3.84% | +131.7% |
| Q2 2022 | $62,090,000 | -25.9% | 9,011,651 | 0.0% | 1.66% | -9.5% |
| Q1 2022 | $83,808,000 | -34.6% | 9,011,651 | 0.0% | 1.83% | -19.0% |
| Q4 2021 | $128,146,000 | -38.7% | 9,011,651 | 0.0% | 2.26% | -22.0% |
| Q3 2021 | $208,980,000 | -6.8% | 9,011,651 | 0.0% | 2.90% | -19.6% |
| Q2 2021 | $224,300,000 | -11.2% | 9,011,651 | 0.0% | 3.60% | -5.4% |
| Q1 2021 | $252,506,000 | -19.7% | 9,011,651 | 0.0% | 3.81% | -13.4% |
| Q4 2020 | $314,507,000 | -30.0% | 9,011,651 | 0.0% | 4.40% | -46.5% |
| Q3 2020 | $449,141,000 | +7.2% | 9,011,651 | 0.0% | 8.22% | +0.6% |
| Q2 2020 | $418,952,000 | – | 9,011,651 | – | 8.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |